ELAN · Elanco Animal Health Inc · Documents

Aug 8

Current report 8-K

Financial results

Aug 8

Quarterly report 10-Q FY2024 Q2, ended Jun 30

Quarterly report for FY2024 Q2

Revenue $1.18B ▲ 12.0% Net loss $50M Diluted EPS -$0.10

Jul 9

Current report 8-K

Completed an acquisition or sale of assets, Regulation FD disclosure

Jul 3

Current report 8-K

Entered into a material agreement, New debt or off-balance-sheet obligation

Jun 4

Current report 8-K Events of May 30

Director or officer change, or executive pay, Charter or bylaw amendment, or fiscal year change, Shareholder vote results

May 8

Earnings call

Q1 2024 earnings call

May 8

Current report 8-K

Financial results

May 8

Quarterly report 10-Q FY2024 Q1, ended Mar 31

Quarterly report for FY2024 Q1

Revenue $1.21B ▼ 4.1% Net income $32M ▼ 68.9% Diluted EPS $0.06 ▼ 71.4%

Apr 19

Proxy statement DEF 14A Meeting May 30, 2024

Proxy statement

Apr 19

Proxy statement DEFA14A

Proxy statement

Apr 8

Proxy statement PRE 14A Meeting May 30, 2024

Proxy statement

Apr 1

Current report 8-K Events of Mar 29

Entered into a material agreement, Director or officer change, or executive pay, Regulation FD disclosure

Feb 29

Proxy statement DEFA14A

Proxy statement

Feb 29

Proxy statement DEFA14A

Proxy statement

Feb 26

Earnings call

Q4 2023 earnings call

Feb 26

Current report 8-K Events of Feb 22

Financial results, Exit or restructuring costs

Feb 26

Annual report 10-K FY2023, ended Dec 31

Annual report for FY2023

Revenue $4.42B ▲ 0.1% Net loss $1.23B Diluted EPS -$2.50

Feb 5

Current report 8-K

Entered into a material agreement, Regulation FD disclosure

Jan 8

Current report 8-K

Regulation FD disclosure

Jan 2

Current report 8-K

Regulation FD disclosure

Nov 7

Earnings call

Q3 2023 earnings call

Nov 7

Current report 8-K

Financial results

Nov 7

Quarterly report 10-Q FY2023 Q3, ended Sep 30

Quarterly report for FY2023 Q3

Revenue $1.07B ▲ 4.1% Net loss $1.1B Diluted EPS -$2.22

Oct 4

Current report 8-K

Regulation FD disclosure

Aug 7

Earnings call

Q2 2023 earnings call

Aug 7

Current report 8-K Events of Aug 3

Entered into a material agreement, Financial results, New debt or off-balance-sheet obligation

Aug 7

Quarterly report 10-Q FY2023 Q2, ended Jun 30

Quarterly report for FY2023 Q2

Revenue $1.06B ▼ 10.0% Net loss $97M Diluted EPS -$0.20

Jul 13

Current report 8-K

Regulation FD disclosure, Other events

Jul 10

Current report 8-K Events of Jul 7

Other events

May 22

Current report 8-K Events of May 18

Director or officer change, or executive pay, Shareholder vote results

May 9

Earnings call

Q1 2023 earnings call

May 9

Current report 8-K

Financial results

May 9

Quarterly report 10-Q FY2023 Q1, ended Mar 31

Quarterly report for FY2023 Q1

Revenue $1.26B ▲ 2.5% Net income $103M ▲ 102.0% Diluted EPS $0.21 ▲ 110.0%

Apr 6

Proxy statement DEF 14A

Proxy statement

Apr 6

Proxy statement DEFA14A

Proxy statement

Mar 1

Current report 8-K/A Events of Feb 21

Financial results

Mar 1

Annual report 10-K FY2022, ended Dec 31

Annual report for FY2022

Revenue $4.41B ▼ 7.4% Net loss $78M Diluted EPS -$0.16

Feb 21

Earnings call

Q4 2022 earnings call

Feb 21

Current report 8-K

Financial results

Jan 31

Current report 8-K

Other events

Jan 9

Current report 8-K

Regulation FD disclosure

Nov 8

Earnings call

Q3 2022 earnings call

Nov 8

Current report 8-K

Financial results

Nov 8

Quarterly report 10-Q FY2022 Q3, ended Sep 30

Quarterly report for FY2022 Q3

Revenue $1.03B ▼ 9.1% Net loss $49M Diluted EPS -$0.10

Sep 8

Current report 8-K Events of Sep 7

Director or officer change, or executive pay, Other events

Aug 8

Earnings call

Q2 2022 earnings call

Aug 8

Current report 8-K

Financial results

Aug 8

Quarterly report 10-Q FY2022 Q2, ended Jun 30

Quarterly report for FY2022 Q2

Revenue $1.18B ▼ 8.0% Net loss $22M Diluted EPS -$0.04

Jun 29

Current report 8-K Events of Jun 28

Entered into a material agreement, New debt or off-balance-sheet obligation

May 19

Current report 8-K Events of May 18

Director or officer change, or executive pay, Charter or bylaw amendment, or fiscal year change, Shareholder vote results